z-logo
open-access-imgOpen Access
Combined C 4d and CD 3 immunostaining predicts immunoglobulin ( Ig)A nephropathy progression
Author(s) -
Faria B.,
Henriques C.,
Matos A. C.,
Daha M. R.,
Pestana M.,
Seelen M.
Publication year - 2015
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12461
Subject(s) - univariate analysis , medicine , pathology , nephropathy , kidney disease , immunology , nephrology , endocrinology , multivariate analysis , diabetes mellitus
Summary A number of molecules have been shown recently to be involved in the pathogenesis and progression of immunoglobulin ( Ig)A nephropathy ( IgAN ). Among these, we have selected C 4d (complement lectin pathway involvement), CD 3 ( T cell marker, traducing interstitial inflammation), transglutaminase 2 ( TG ase‐2, involved in tissue fibrosis development) and p‐extracelluar‐regulated kinase ( ERK) 1/2 (protein kinase intracellular signaling molecule) to perform a panel of immunohistological biomarkers and assess its predictive value for disease progression. Immunohistochemical staining of these biomarkers was performed in paraffin sections from 74 renal biopsy cases with the clinical diagnosis of IgAN . Association between score analysis of these parameters and disease course was assessed through univariate and multivariate analysis, including baseline clinical and histological data. Univariate analysis showed that glomerular C 4d, tubulointerstitial TG ase2 and CD 3 scores were associated with baseline proteinuria and disease progression. Multivariate analysis showed that only baseline estimated glomerular filtration rate (e GFR ), C 4d and CD 3 were associated independently with progressive kidney disease (decline of at least 50% in the e GFR or progression to end‐stage renal disease ( ESRD) during the follow‐up period). Establishing an accurate prediction model for IgAN progression is still a matter of research in clinical nephrology. The complement system, particularly lectin pathway activation, and T cell activation, have been shown previously to be potential modifiers of the disease course. Here we show that the combination of two histological biomarkers ( C 4d and CD 3) can be a powerful predictor of IgAN progression and a potential useful tool for the clinical approach of this disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom